Sees Q3 adjusted EBITDA $65M-$70M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASTH:
- Astrana Health price target lowered to $50 from $70 at BTIG
- Astrana Health’s Strategic Acquisition and Financial Guidance Boost: Analyst Recommends Buy
- Astrana Health Completes Acquisition of Prospect Health
- Astrana Health management to meet with Truist
- Astrana Health Approves 2024 Equity Incentive Plan